This content is machine translated Hematology and medical oncology The world of hematology and oncology research The rapid technological developments in diagnostics and innovations in multimodal therapy in the field of hematology and medical oncology were the focus of the annual conference. While immunotherapies with monoclonal…
View Post 5 min This content is machine translated Therapy and management of progressive pulmonary fibrosis (PPF) Often more questions than answers in the end Some patients with interstitial lung disease (ILD) have a fibrotic phenotype. Some of these patients respond – at least in the short term – to therapy. In some cases, however,…
View Post 7 min This content is machine translated Harm reduction with e-cigarettes If not stop, then at least minimize the damage Worldwide, around 30-40% of cardiovascular diseases are attributable to smoking. This figure is around 80% for cancer cases and 63% for COPD cases. Around half of healthcare costs can be…
View Post 10 min This content is machine translated GLP-1 agonists continue to gain ground Semaglutide in patients with obesity and heart failure It has long been known that the active ingredient class of glucagon-like peptide-1 agonists (GLP-1) reduces cardiovascular consequences in diabetics and leads to significant weight loss in patients with obesity.…
View Post 8 min This content is machine translated Hematology From anemia to blood cancer – the latest findings at a glance Hematology covers a broad spectrum of indications with very heterogeneous disease patterns. Accordingly, intensive research is being carried out to provide patients with effective treatment. Rarer diseases are examined just…
View Post 8 min This content is machine translated Rare skin diseases Patience and expertise are required for bullous pemphigoid Direct and indirect immunofluorescence are still the gold standard for the detection of specific antibodies and autoantibodies in bullous pemphigoid. Highly effective topical steroids or systemic corticosteroids are recommended as…
View Post 5 min This content is machine translated Atopic dermatitis Focus on mediators of type 2 inflammation The pathomechanisms of atopic dermatitis (AD) are becoming increasingly better understood. A genetically determined immunological imbalance is characterized by an increased Th2 response and is associated with the production of…
View Post 4 min This content is machine translated SGLT-2-i in type 2 diabetes and CVD Cardioprotective mechanisms of action of empagliflozin – what’s new? Empagliflozin is known to reduce the risk of atherosclerotic cardiovascular disease (CVD) in people with type 2 diabetes and high cardiovascular risk. The mechanisms underlying these effects are not yet…
View Post 3 min This content is machine translated IBD and exposure to altitude Don’t fly so high, sick patient Inflammatory bowel disease (IBD) can have many causes. However, the connection with exposure to altitude has not yet been investigated prospectively. Scientists from Zurich have now approached this question with…
View Post 4 min This content is machine translated AID systems for type 1 diabetes New real-world data shows: AI makes the difference In hybrid closed-loop systems, algorithms control the automated insulin delivery (AID). Compared to conventional insulin administration, this not only has a favorable effect on HbA1c values, but also on patient-oriented…
View Post 4 min This content is machine translated Derma-oncology Current study results underline the risk of skin cancer The EADV Congress is the annual international congress for the latest scientific advances and research in dermatology and venereology. The diverse scientific program brings together healthcare professionals, organizations and industry…
